The type II transforming growth factor-β receptor as a tumor-suppressor gene

Current Opinion in Oncology

Volumn 8, Issue 1, 1996, Pages 49-53

  Brattain, Michael G ^a   Markowitz, Sanford D ^b   Willson, James K V ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AUTOCRINE EFFECT; COLORECTAL CANCER; GENE EXPRESSION; GENE MUTATION; GENE REPLICATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; STOP CODON; TUMOR SUPPRESSOR GENE;

EID: 0029878318     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199601000-00009     Document Type: Review

References (26)

1. Roberts AB, Sporn MB: The Transforming Growth Factor βs. In Peptide Growth Factors and Their Receptors. Edited by Sporn MB, Roberts AB. Heidelberg: Springer-Verlag; 1990:419-472.
2. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGFβ type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992, 68:775-785.
3. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schultz P, Heldin C-H, Miyazono K: Cloning of TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993, 75:681-692.
4. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe K, Wang XF: A transforming growth factor β type I receptor that signals to activate gene expression. Science 1994, 263:87-89.
5. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J: Mechanism of activation of TGF-β receptors. Nature 1994, 370:341-347.
6. López-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massagué J: Structure and expression of the membrane proteoglycan betaglycan, a component of the TGFβ receptor system. Cell 1991, 67:785-795.
7. Wang XF, Lin HF, Eaton E, Downward J, Lodish HF, Weinberg RA: Expression cloning and characterization of the TGFβ type III receptor. Cell 1991, 67:797-805.
8. Matkowitz S, Wang J, Myeroff L, Parsons R, Sun L-Z, Lutterbaugh J, Fan RS, Zborowski E, Kinzler KW, Vogelslein B, Brattain M, Willson JKV: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995, 268:1336-1338. This article shows the importance of TGFβ RII receptor mutation in determining malignancy and loss of TGFβ response.
9. Wang J, Sun L-Z, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV, Brattain MG: Demonstration that mutation of the type II TGFβ receptor inactivates its tumor suppressor activity in RER positive colon carcinoma cells. J Biol Chem 1996, 270:22044-22049. This paper shows the relationship between RII loss to human malignancy.
10. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zwiebaum A: Epithelial polarity, villin expression and enterocytic differentiation of cultured human colon carcinoma cells: a survey of 20 cell lines. Cancer Res 1988, 48:1936-1942.
11. 1. Exp Cell Res 1989, 181:442-453.
12. 1. Oncogene 1991, 6:1471-1476.
13. Markowitz S, Myeroff L, Cooper M, Traicoff J, Kochera M, Lutterbaugh J, Swiriduk M, Willson JKV: A benign cultured colon adenoma bears 2 genetically altered colon cancer oncogenes that progressed to tumorigenicity and TGFβ independence without inactivating the p53 tumor suppressor gene. J Clin Invest 1994, 93:1005-1013.
14. Hafez MM, Infante D, Winawer S, Friedman E: TGFβ acts as an autocrine negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Cell Growth Diff 1990, 1:617-626.
15. Arteaga CL, Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM: Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies: evidence for negative autocrine regulation by transforming growth factor β. Cell Growth Diff 1990, 1:367-374.
16. 1 is an autocrine negative growth regulator of human colon carcinoma FET cells in vitro as revealed by transfection of an anti-sense expression vector. J Cell Biol 1992, 116:186-197.
17. 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Diff 1993, 4:115-123.
18. Sun L-Z, Wu G, Willson JKV, Zborowska E, Yang J, Rajakarkunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG: Expression of TGFβ type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 1994, 269:26449-26455.
19. Hagan KW, Ruiz-Echevarria MJ, Quan Y, Peltz SW: Characterization of cis-acting sequences and decay intermediates involved in nonsense mediated mRNA turnover. Mol Cell Biol 1995, 15:809-823.
20. Eshelman J, Markowitz S: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 1995, 7:83-89.
21. Park K, Kim SJ, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MB: Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci U S A 1994, 91:8772-8776.
22. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D: Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci U S A 1994, 91:6002-6006.
23. Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS: Reduced surface expression of TGFβ receptor type II nitrogen-activated T cells from Sézary patients. Proc Natl Acad Sci U S A 1995, 92:5501-5505.
24. 1 can induce estrogen Independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ 1993, 4:193-201.
25. 1 in human breast cancer in vivo following tamoxlfen treatment. Cancer Res 1992, 52:4261-4264.
26. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987, 48:417-428.